RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,823 | -51.2% | 8,151 | +55.1% | 0.00% | – |
| Q4 2022 | $7,828 | -21.7% | 5,254 | -58.9% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 12,785 | +112.8% | 0.00% | – |
| Q1 2022 | $11,000 | +22.2% | 6,007 | +19.3% | 0.00% | – |
| Q4 2021 | $9,000 | -25.0% | 5,034 | -15.5% | 0.00% | – |
| Q3 2021 | $12,000 | -29.4% | 5,956 | -17.6% | 0.00% | – |
| Q2 2021 | $17,000 | +88.9% | 7,227 | +117.6% | 0.00% | – |
| Q1 2021 | $9,000 | +12.5% | 3,321 | +22.3% | 0.00% | – |
| Q4 2020 | $8,000 | -72.4% | 2,715 | -57.5% | 0.00% | – |
| Q2 2020 | $29,000 | -71.0% | 6,390 | -47.6% | 0.00% | – |
| Q1 2020 | $100,000 | -84.0% | 12,197 | -64.2% | 0.00% | – |
| Q4 2019 | $624,000 | +216.8% | 34,073 | +91.7% | 0.00% | – |
| Q3 2019 | $197,000 | +155.8% | 17,777 | +132.6% | 0.00% | – |
| Q2 2019 | $77,000 | +220.8% | 7,642 | +85.3% | 0.00% | – |
| Q1 2019 | $24,000 | -70.4% | 4,125 | -63.7% | 0.00% | – |
| Q4 2018 | $81,000 | +30.6% | 11,354 | +30.7% | 0.00% | – |
| Q3 2018 | $62,000 | +138.5% | 8,690 | +65.5% | 0.00% | – |
| Q2 2018 | $26,000 | +52.9% | 5,251 | +231.7% | 0.00% | – |
| Q1 2018 | $17,000 | +88.9% | 1,583 | +71.0% | 0.00% | – |
| Q4 2017 | $9,000 | +80.0% | 926 | +69.3% | 0.00% | – |
| Q3 2017 | $5,000 | +400.0% | 547 | +447.0% | 0.00% | – |
| Q2 2017 | $1,000 | -85.7% | 100 | -87.7% | 0.00% | – |
| Q4 2016 | $7,000 | -41.7% | 812 | -48.1% | 0.00% | – |
| Q2 2016 | $12,000 | -42.9% | 1,565 | -56.0% | 0.00% | – |
| Q1 2016 | $21,000 | +2000.0% | 3,555 | +3102.7% | 0.00% | – |
| Q4 2015 | $1,000 | -97.3% | 111 | -96.3% | 0.00% | – |
| Q3 2015 | $37,000 | +270.0% | 3,038 | +183.1% | 0.00% | – |
| Q1 2015 | $10,000 | -28.6% | 1,073 | -78.1% | 0.00% | – |
| Q4 2014 | $14,000 | – | 4,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |